Imperial College London

Professor Sarah Fidler BSc. MBBS. FRCP. PhD

Faculty of MedicineDepartment of Infectious Disease

Professor of HIV and Communicable Diseases
 
 
 
//

Contact

 

+44 (0)20 7594 6230s.fidler

 
 
//

Location

 

clinical trial centre Winston Churchill wingMedical SchoolSt Mary's Campus

//

Summary

 

Summary

Professor Sarah Fidler is a clinical academic who provides care for people living with HIV. Her main research interest is in the diagnosis, treatment and cure of HIV infection. 

Publications

Journals

Fogel JM, Wilson EA, Piwowar-Manning E, et al., 2022, HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART), Journal of the International Aids Society, Vol:25

Hargreaves JR, Pliakas T, Hoddinott G, et al., 2022, The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa, Journal of the International Aids Society, Vol:25

Ogbe A, Pace M, Bittaye M, et al., 2022, Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV, Jci Insight, Vol:7

Lee MJ, Collins S, Babalis D, et al., 2022, The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial, Trials, Vol:23, ISSN:1745-6215

Bareng OT, Moyo S, Zahralban-Steele M, et al., 2022, HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana, Journal of Antimicrobial Chemotherapy, Vol:77, ISSN:0305-7453, Pages:1385-1395

More Publications